Highlights • Microbiome-targeted interventions as novel therapeutic approaches for Alzheimer’s disease. • Emphasizing the intricate interplay between gut microbiota composition, neuroinflammation, and disease pathogenesis. • The gut microbiota, which produces a lot of amyloids, LPS, and other toxins, may play a role in systemic inflammation and the breakdown of physiological barriers.
All Keywords
【저자키워드】 Microbiome, Alzheimer's disease, neurodegenerative disorders, Gut-brain axis,
【저자키워드】 Microbiome, Alzheimer's disease, neurodegenerative disorders, Gut-brain axis,